NSE: AUROPHARMA
BSE:
53.61/100
Quality Score
Medium Financial Strength41.33/100
Valuation Score
Mid Valuation64.64/100
Technical Score
Technically Moderately BullishPeer Comparison
All values except ratios in INR(Crores)
Quarterly Results
All values except ratios in INR(Crores)
Annual Results
All values except ratios in INR(Crores)
Financial Ratios
All values except ratios in INR(Crores)
Balance Sheet
All values except ratios in INR(Crores)
Cash Flow
All values except ratios in INR(Crores)
Peer Comparison
Volume Analysis
SMA/EMA (Moving Average) Analysis
Price Change Analysis
Pivot Level
Active Candlesticks
Bullish Candlestick Patterns
Bearish Candlestick Patterns
What is QVT?
Quality
The Quality Score is based on company's financial and management quality and long term performance. Quality scores above 55 are considered good (G) and below 35 are considered bad (B). Whereas, scores between 35-55 are considered neutral/Medium/Middle (M).
- 10055Good (G) Q
- 35Neutral, Medium, Middle (M) Q
- 0Bad (B) Q
Value
The Valuation Score tracks how expensive the stock is versus its peers. Valuation scores above 50 are considered good (G) and below 30 are considered bad (B). Scores between 30-50 are considered neutral/Medium/Middle (M).
- 10050Good (G) Q
- 30Neutral, Medium, Middle (M) Q
- 0Bad (B) Q
Technical
The Technical Score tracks the bullishness or bearishness of a particular stock relative to the entire stock universe. A Technical Score above 59 is considered good (G) and below 30 is considered bad (B). Scores between 30-59 are considered neutral/Medium/Middle (M).
- 10059Good (G) Q
- 30Neutral, Medium, Middle (M) Q
- 0Bad (B) Q
S
Strengths 10
- Strong Momentum: Price above short, medium and long term moving averages
- MACD Crossover Above Signal Line
- Growth in Net Profit with increasing Profit Margin (QoQ)
- Company with Low Debt
- Increasing Revenue every quarter for the past 3 quarters
- Increasing profits every quarter for the past 3 quarters
- Book Value per share Improving for last 2 years
- Company with decreasing Promoter pledge
- FII / FPI or Institutions increasing their shareholding
- Near 52 Week High
W
Weaknesses 6
- Promoters increased pledged shares QoQ
- Negative Breakdown First Support (LTP < S1)
- Inefficient use of capital to generate profits - RoCE declining in the last 2 years
- Inefficient use of shareholder funds - ROE declining in the last 2 years
- Inefficient use of assets to generate profits - ROA declining in the last 2 years
- Annual net profit declining for last 2 years
O
Opportunities 2
- Highest Recovery from 52 Week Low
- RSI indicating price strength
T
Threats 1
- Red Flags: Firms linked to ongoing regulatory investigations/legal cases
